- Home
- COEP vs PYN Comparison
COEP vs PYN Comparison
Compare COEP & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- PYN
- Stock Information
- Founded
- COEP 2017
- PYN 2002
- Country
- COEP United States
- PYN United States
- Employees
- COEP N/A
- PYN N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- PYN Investment Managers
- Sector
- COEP Health Care
- PYN Finance
- Exchange
- COEP Nasdaq
- PYN Nasdaq
- Market Cap
- COEP 32.4M
- PYN 33.5M
- IPO Year
- COEP N/A
- PYN N/A
- Fundamental
- Price
- COEP $12.45
- PYN $5.81
- Analyst Decision
- COEP
- PYN
- Analyst Count
- COEP 0
- PYN 0
- Target Price
- COEP N/A
- PYN N/A
- AVG Volume (30 Days)
- COEP 111.8K
- PYN 19.9K
- Earning Date
- COEP 03-25-2025
- PYN 01-01-0001
- Dividend Yield
- COEP N/A
- PYN 5.07%
- EPS Growth
- COEP N/A
- PYN N/A
- EPS
- COEP N/A
- PYN N/A
- Revenue
- COEP N/A
- PYN N/A
- Revenue This Year
- COEP N/A
- PYN N/A
- Revenue Next Year
- COEP N/A
- PYN N/A
- P/E Ratio
- COEP N/A
- PYN N/A
- Revenue Growth
- COEP N/A
- PYN N/A
- 52 Week Low
- COEP $2.31
- PYN $4.84
- 52 Week High
- COEP $13.70
- PYN $6.60
- Technical
- Relative Strength Index (RSI)
- COEP 63.21
- PYN 53.96
- Support Level
- COEP $8.65
- PYN $5.72
- Resistance Level
- COEP $12.95
- PYN $5.89
- Average True Range (ATR)
- COEP 1.64
- PYN 0.04
- MACD
- COEP -0.16
- PYN 0.01
- Stochastic Oscillator
- COEP 75.25
- PYN 55.22
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest
PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.